Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLYNYSE:ENOVNASDAQ:LIVNNASDAQ:LMAT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.43-2.0%$2.80$0.67▼$4.98$602.45M2.62.87 million shs1.97 million shsENOVEnovis$35.01-0.3%$36.70$29.32▼$56.43$2.00B1.86748,512 shs890,659 shsLIVNLivaNova$37.26$39.14$32.48▼$64.48$2.03B0.9623,006 shs409,635 shsLMATLeMaitre Vascular$91.61-0.2%$87.08$62.50▼$109.58$2.07B0.89161,240 shs106,920 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network+4.20%+6.21%-9.16%-36.33%+250.78%ENOVEnovis+3.87%+10.09%-10.81%-26.48%-37.45%LIVNLivaNova+2.56%+4.72%-6.66%-22.62%-33.39%LMATLeMaitre Vascular+2.48%+6.35%+7.85%-5.29%+43.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBFLYButterfly Network1.6332 of 5 stars2.52.00.00.03.51.70.6ENOVEnovis2.6563 of 5 stars3.41.00.00.03.01.71.9LIVNLivaNova3.6518 of 5 stars4.43.00.00.03.21.71.3LMATLeMaitre Vascular2.2767 of 5 stars1.31.03.30.04.03.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 3.00Buy$3.0023.46% UpsideENOVEnovis 2.75Moderate Buy$58.5067.10% UpsideLIVNLivaNova 2.88Moderate Buy$61.1764.16% UpsideLMATLeMaitre Vascular 2.67Moderate Buy$95.253.97% UpsideCurrent Analyst Ratings BreakdownLatest BFLY, LMAT, LIVN, and ENOV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2025ENOVEnovisNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$64.00 ➝ $64.004/2/2025ENOVEnovisNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$64.00 ➝ $64.003/17/2025BFLYButterfly NetworkWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform3/17/2025LIVNLivaNovaNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$64.00 ➝ $64.003/7/2025LIVNLivaNovaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$58.00 ➝ $56.003/3/2025LIVNLivaNovaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$64.00 ➝ $55.002/28/2025LMATLeMaitre VascularLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$105.00 ➝ $110.002/28/2025LMATLeMaitre VascularOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform2/28/2025LMATLeMaitre VascularBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform2/27/2025ENOVEnovisNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$65.00 ➝ $64.002/26/2025LIVNLivaNovaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$70.00 ➝ $60.00(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$82.06M7.19N/AN/A$1.06 per share2.29ENOVEnovis$2.11B0.95$5.10 per share6.86$62.66 per share0.56LIVNLivaNova$1.25B1.62$3.34 per share11.15$23.72 per share1.57LMATLeMaitre Vascular$219.86M9.40$1.62 per share56.52$13.38 per share6.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$133.70M-$0.33N/AN/AN/A-129.25%-42.68%-30.31%5/2/2025 (Estimated)ENOVEnovis-$33.26M-$14.29N/A10.97N/A-5.95%4.39%2.80%5/8/2025 (Estimated)LIVNLivaNova$17.55M$1.1488.7111.87N/A1.91%13.81%7.07%4/29/2025 (Estimated)LMATLeMaitre Vascular$30.10M$1.9450.0642.222.2219.40%13.15%11.47%5/1/2025 (Estimated)Latest BFLY, LMAT, LIVN, and ENOV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025ENOVEnovis$0.74N/AN/AN/A$558.80 millionN/A5/7/2025Q1 2025LIVNLivaNova$0.75N/AN/AN/A$302.34 millionN/A5/2/2025Q1 2025BFLYButterfly Network-$0.09N/AN/AN/A$21.16 millionN/A5/1/2025Q1 2025LMATLeMaitre Vascular$0.50N/AN/AN/A$57.61 millionN/A2/27/2025Q4 2024LMATLeMaitre Vascular$0.49$0.49N/A$0.49$55.99 million$55.81 million2/26/2025Q4 2024ENOVEnovis$0.92$0.98+$0.06-$12.05$555.14 million$560.98 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/AENOVEnovisN/AN/AN/AN/AN/ALIVNLivaNovaN/AN/AN/AN/AN/ALMATLeMaitre Vascular$0.800.87%+13.30%41.24%14 YearsLatest BFLY, LMAT, LIVN, and ENOV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/18/2025LMATLeMaitre Vascularquarterly$0.200.9%3/13/20253/13/20253/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A4.662.95ENOVEnovis0.402.271.12LIVNLivaNova0.463.372.87LMATLeMaitre VascularN/A7.745.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%ENOVEnovis98.45%LIVNLivaNova97.64%LMATLeMaitre Vascular84.64%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network27.28%ENOVEnovis2.40%LIVNLivaNova0.27%LMATLeMaitre Vascular10.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460242.92 million154.94 millionOptionableENOVEnovis6,80057.11 million55.49 millionOptionableLIVNLivaNova2,90054.35 million54.15 millionOptionableLMATLeMaitre Vascular49022.56 million20.06 millionOptionableBFLY, LMAT, LIVN, and ENOV HeadlinesRecent News About These CompaniesMassar Capital Management LP Invests $284,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 24 at 6:51 AM | marketbeat.comCramer on LeMaitre Vascular (LMAT): “A Great Under-the-Radar Medical Device Stock”April 23 at 10:06 PM | msn.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Bridgewater Associates LPApril 23 at 4:07 AM | marketbeat.comRaymond James Financial Inc. Invests $14.90 Million in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 23 at 3:49 AM | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Acquired by Invesco Ltd.April 22 at 3:31 AM | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT) and UnitedHealth (UNH)April 21, 2025 | markets.businessinsider.com5,944 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Bought by Synovus Financial CorpApril 20, 2025 | marketbeat.com84,517 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Rockefeller Capital Management L.P.April 19, 2025 | marketbeat.comQ4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty StocksApril 17, 2025 | finance.yahoo.comTownsquare Capital LLC Has $5.07 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 16, 2025 | marketbeat.comFederated Hermes Inc. Grows Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 15, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $23.90 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 15, 2025 | marketbeat.comGeode Capital Management LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 15, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Arrowstreet Capital Limited PartnershipApril 14, 2025 | marketbeat.comJPMorgan Chase & Co. Boosts Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 14, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by F M Investments LLCApril 13, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 54,184 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 12, 2025 | marketbeat.comRanger Investment Management L.P. Sells 27,226 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)April 11, 2025 | marketbeat.comLeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock?April 10, 2025 | zacks.comLeMaitre Vascular (NASDAQ:LMAT) Stock Price Down 10.5% - Here's What HappenedApril 9, 2025 | marketbeat.comLeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025April 7, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBFLY, LMAT, LIVN, and ENOV Company DescriptionsButterfly Network NYSE:BFLY$2.43 -0.05 (-2.02%) Closing price 03:59 PM EasternExtended Trading$2.49 +0.06 (+2.47%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.Enovis NYSE:ENOV$35.01 -0.11 (-0.31%) Closing price 03:59 PM EasternExtended Trading$35.09 +0.08 (+0.23%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.LivaNova NASDAQ:LIVN$37.26 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$37.27 +0.01 (+0.03%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.LeMaitre Vascular NASDAQ:LMAT$91.61 -0.15 (-0.16%) Closing price 04:00 PM EasternExtended Trading$89.14 -2.47 (-2.70%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
